Diabetic Neuropathic Pain Market Growth, Competitive Scenario & Forecasts to 2016: Radiant Insights, Inc

Diabetic Neuropathic Pain - Pipeline Market Review, H1

2016 By Radiant Insights

Summary

Global Markets Direct's, 'Diabetic Neuropathic Pain - Pipeline Review, H1 2016', provides an overview of

the Diabetic Neuropathic Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diabetic

Neuropathic Pain, complete with analysis by stage of development, drug target, mechanism of action

(MoA), route of administration (RoA) and molecule type. The report also covers the descriptive

pharmacological action of the therapeutics, its complete research and development history and latest

news and press releases. Additionally, the report provides an overview of key players involved in

therapeutic development for Diabetic Neuropathic Pain and features dormant and discontinued

projects.

To Get Full Report Click Here @ http://www.radiantinsights.com/research/diabetic-neuropathic-painpipeline-review-h1-2016

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy

areas and nearly 3,000 indications. The report is built using data and information sourced from Global

Markets Direct's proprietary databases, company/university websites, clinical trial registries,

conferences, SEC filings, investor presentations and featured press releases from company/university

sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic

review following a stringent set of processes to ensure that all the profiles are updated with the latest

set of information. Additionally, various dynamic tracking processes ensure that the most recent

developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios,

enhances decision making capabilities and helps to create effective counter strategies to gain

competitive advantage.

Note*: Certain sections in the report may...